Classic Hodgkin Lymphoma — Trials

Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05714553	NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours	terminated	Phase 1 / Phase 2	19	NuCana plcOTHER	1	Jul 23, 2026	clinicaltrials
NCT04788043	Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma	terminated	Phase 2	8	Ranjana AdvaniOTHER	1	Jun 30, 2026	clinicaltrials
NCT05179603